MYGN EBITDA

Myriad Genetics Inc · EBITDA

MYGN logo

MYGN EBITDA

Latest reported-$45.20M
MYGN TTM EBITDA (-$11.70M → -$45.20M)
High-resolution chart · PNG

MYGN ebitda history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Myriad Genetics Inc EBITDA — Trailing twelve months (TTM) (USD)
Period endingEBITDA (USD)
-45,200,000
-334,200,000
-330,900,000
-362,600,000
-357,600,000
-63,900,000
-59,400,000
-52,100,000
-93,400,000
-174,400,000
-197,400,000
-218,600,000
-202,800,000
-104,900,000
-84,700,000
-76,900,000
8,500,000
28,000,000
12,300,000
60,100,000
-18,100,000
-70,900,000
-153,600,000
-162,400,000
-140,500,000
-88,900,000
46,800,000
62,500,000
85,000,000
97,400,000
99,400,000
93,800,000
169,800,000
176,800,000
172,400,000
180,600,000
97,200,000
106,200,000
133,400,000
157,600,000
193,800,000
194,309,000
186,809,000
177,309,000
159,109,000
175,082,000
191,749,000
234,887,000
288,263,000
297,651,000
298,982,000
271,374,000
236,891,000
218,335,000
206,636,000
196,562,000
189,388,000
183,429,000
178,654,000
171,268,000
164,997,000
160,749,000
152,128,000
148,015,000
142,158,000
178,263,000
180,928,000
180,334,000
164,411,000
157,372,000
114,175,000
71,943,000
46,861,000
-31,870,000
-33,478,000
-13,716,000
-17,445,000
-19,364,000
-22,464,000
-43,566,000
-38,733,000
-33,751,000
-32,701,000
-33,931,000
-34,652,000
-36,920,000
-37,444,000
-37,251,000
-36,869,000
-33,774,000
-28,880,000
-26,044,000
-22,071,000
-21,949,769
-20,366,359
-17,014,398
-14,163,398
-10,378,109
-9,443,237
-8,990,794
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.